How PM2.5 wrecks your airways and how the damage might be reversed
en-GBde-DEes-ESfr-FR

How PM2.5 wrecks your airways and how the damage might be reversed


Researchers from The University of Osaka reveal the mechanism by which a common air pollutant impairs our airway defense mechanisms

Osaka, Japan – Air pollution is the second leading risk factor for death globally, with most of the world population subject to harmful air pollutant levels. However, the mechanisms behind air pollution affecting human health and mortality remain poorly understood, leaving treatment strategies unknown.

In a recent study published in The Journal of Clinical Investigation, a multi-institutional research team led by The University of Osaka have discovered the mechanism by which exposure to ≤2.5 µm air pollutants (PM2.5) causes airway dysfunction.

A large portion of natural and human-made air pollutants fall under the PM2.5 category: dust, vehicle exhaust and wildfire smoke, for example. When inhaled, it causes severe airway damage and respiratory diseases. To understand how exactly air pollution particles affect the respiratory system, the researchers ran a series of experiments on mice. They exposed the mice to environmental pollutants and then examined their respiratory tracts for changes in structure and function.

“Our results were quite informative. We found that PM2.5 air pollutants negatively affect mucociliary clearance, a major protective mechanism in the respiratory tract,” says lead author, Noriko Shinjyo. “Mucociliary clearance basically involves trapping pollutants in a sticky mucus and then sweeping the pollutants out the airway with hair-like projections called cilia.”

The researchers found that the pollutants caused oxidative injury in the airways, which facilitates the formation of lipid peroxide-derived aldehydes. This substance is a reactive aldehyde that damages the protective cells in the airway, including airway cilia. As damaged airway cells and cilia can no longer move debris and pollutants out of the airways, the risk of infection is increased.

The team continued their investigation to find out how to restore normal cellular function and reverse damage. For this, the researchers investigated how one gene from the ALDH family, known to protect the body against harmful aldehydes, may counter the effect of airway pollutants.

“Aldehyde dehydrogenase (ALDH1A1) is an enzyme that plays an important role in protection against aldehydes. We used experimental mice that lacked ALDH1A1 to investigate the impact of air pollutants without the gene,” explains Yasutaka Okabe, senior author. “As expected, the mice had impaired cilia formation and function and high levels of aldehydes.”

The research team also found that the absence of ALDH1A1 left the cells at a higher risk of serious respiratory infection when exposed to air pollutants. The importance of ALDH1A1 was further emphasized when it was also found that drug-enhanced ALDH1A1 levels improved the mice’s mucociliary function in response to pollutants.

Owing to the researchers’ work, we now know how PM2.5 pollutants disrupt the lungs' self-cleaning system. What’s more, their work offers a potential therapeutic target: the enzyme ALDH1A1. As air pollution continues to be a major health concern worldwide, these findings could be key for new treatments that strengthen our respiratory defenses.

###

The article, “Aldehyde metabolism governs resilience of mucociliary
clearance to air pollution exposure,” was published in The Journal of Clinical Investigation at DOI: https://doi.org/10.1172/JCI191276.
Title: Aldehyde metabolism governs resilience of mucociliary clearance to air pollution exposure
Journal: The Journal of Clinical Investigation
Authors: Noriko Shinjyo, Haruna Kimura, Tomomi Yoshihara, Jun Suzuki, Masaya Yamaguchi, Shigetada Kawabata, and Yasutaka Okabe
DOI: 10.1172/JCI191276
Funded by: Japan Society for the Promotion of Science
Attached files
  • Fig. 1 Exposure to PM2.5 induces the generation of reactive aldehydes, resulting in ciliary dysfunction., Original content, No restrictions., Yasutaka Okabe (Created with BioRender.com)
Regions: Asia, Japan
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement